Amit Vohra, PhD, MBA, serves as the Chairman of the Board at Promaxo, bringing a wealth of expertise in medtech innovation and strategic growth. His extensive background in launching and scaling startups has been instrumental in guiding Promaxo’s vision and expansion. With a strong focus on leveraging technology to improve patient outcomes, he is committed to advancing the company’s mission to transform prostate care, guide Promaxo’s journey as a leader in MRI-guided interventions.
1 Price, John H., et al. “Accurate Prostate Biopsies Using Low-Field Portable Intervention MRI in an Ambulatory Surgical Center.” IPCU, 2024.
2 Sze, C., et al (2023). “Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy.” The Prostate, 83(7), 656-662. https://doi.org/10.1002/pros.24499.
3 Sze, C., et al, (2022) “Cost-efficient analysis of a portable low field magnetic resonance imaging system for prostate cancer diagnosis.” Front.
Urol.2:966862. doi: 10.3389/fruro.2022.966862.
4 Chiragzada, S., et al. “Advantageous Detection of Significant Prostate Cancer Using a Low-Field, Office-Based MRI System.” Cureus. 2022 Dec 1;14(12):e32105. doi:10.7759/cureus.32105. PMID:
36601170; PMCID: PMC9805358.
5 Data on file.
6 Xiang, Jianjian, et al. “Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: A systematic review and meta-analysis.ˮ World Journal of Surgical Oncology, vol. 17, no. 1,13 Feb. 2019, https://doi.org/10.1186/s12957-019-1573-0.
*The Promaxo Robot is not yet available for commercial sale.
© 2025 Promaxo, Inc. All rights reserved.